News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
124 Results
Type
Article (34)
Press Release (90)
Section
Business (43)
Deals (2)
Drug Development (25)
FDA (1)
Job Trends (5)
News (63)
Policy (1)
Tag
Academia (2)
Alliances (9)
Alzheimer's disease (7)
Approvals (1)
Best Places to Work (2)
Clinical research (20)
Collaboration (1)
COVID-19 (3)
Earnings (1)
Events (41)
Executive appointments (2)
FDA (1)
GLP-1 (2)
Government (1)
Healthcare (1)
Infectious disease (3)
Job creations (4)
Mergers & acquisitions (2)
Neurodegenerative disease (1)
Neuroscience (10)
NextGen Class of 2024 (3)
Parkinson's disease (3)
People (34)
Phase I (12)
Phase II (10)
Phase III (5)
Postmarket research (1)
Preclinical (1)
Real estate (1)
Regulatory (1)
Research institute (1)
Special edition (1)
Startups (1)
United States (7)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (25)
2024 (23)
2023 (28)
2022 (18)
2021 (10)
2020 (14)
2019 (15)
2018 (4)
2017 (9)
2016 (2)
2014 (1)
Location
Asia (8)
Europe (15)
Massachusetts (7)
124 Results for "cerevance".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cerevance’s CVN293 Demonstrated Positive Phase 1 Results in Healthy Volunteers
November 11, 2024
·
4 min read
Press Releases
Sarah Sheikh Joins Cerevance’s Board of Directors
October 18, 2024
·
3 min read
Genetown
Cerevance Presents at The Federation of European Neuroscience Societies (FENS) Forum 2024
Cerevance will deliver a poster presentation at the upcoming Federation of European Neuroscience Societies (FENS) Forum 2024, taking place in Vienna, Austria, from June 25 – 29, 2024.
June 18, 2024
·
2 min read
Press Releases
Cerevance Achieves Second Milestone in Research Collaboration with Merck
October 8, 2024
·
2 min read
Genetown
Cerevance to Participate at Upcoming Investor Conferences
Cerevance today announced that company management will participate in the following investor conferences: Wells Fargo Virtual Private Biotech Symposium, May 6, 2024.
April 29, 2024
·
2 min read
Press Releases
Cerevance Doses First Patient in Pivotal Phase 3 ARISE Trial of Solengepras for Treatment of Parkinson’s Disease
November 18, 2024
·
4 min read
Business
Cerevance to Participate in a Panel Discussion at Fierce Biotech Summit 2024
September 23, 2024
·
2 min read
Genetown
Cerevance to Participate in Precision Neurotherapeutics Panel During the 2024 BIO International Convention
Cerevance announced that Craig Thompson, chief executive officer, will participate in a panel at the 2024 BIO International Convention, taking place in San Diego, CA from June 3 – 6, 2024.
May 20, 2024
·
2 min read
Genetown
Cerevance Presents at 35th Symposium on Medicinal Chemistry in Eastern England
Cerevance today announced plans to deliver an oral presentation at the upcoming 35th Symposium on Medicinal Chemistry, taking place in Hatfield, United Kingdom April 25, 2024.
April 17, 2024
·
2 min read
News
Cerevance Announces Publication of Positive Phase 2 Results of Solengepras for the Treatment of Parkinson’s Disease in eClinicalMedicine
October 21, 2024
·
5 min read
1 of 13
Next
